Review quality of purchased products. Enter order details into internal databases. Maintain updated records of purchased products, delivery information and invoices.
For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. IPCA is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, IPCA is one of the worlds largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the worlds most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.
Masters in Life/Pharmaceutical Sciences, Biophysics, Biology, or similar disciplines are encouraged to apply. M.S./M.Pharm in Pharmacology/Pharmacology and Toxicology, M.Sc. in Medical Pharmacology/M.Sc. Biotechnology / M.Pharm with preferably good NET/GATE/CSIR qualification
Pharm D/ MPharm / BDS/ MPH/ MSc (Biostatistics)/ MSc Clinical Research / MSc Nursing. OR MSc Life Science/ BTech Biotechnology with Post graduate Diploma in Clinical Research. To establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative
As HCE the incumbent is expected to be a vital interface between the Company and the medical profession by briefing them on the scientific features and patient care benefits in respect of companys products, consistently achieve budgeted sales of the products in the assigned territory through planned coverage and systematic implementation of promotional strategies and customer service initiatives and reporting thereof.
Sciences or Pharmacy Graduates B.Sc./M.Sc./B. Pharm./M.Pharm. with 0 to 2 years Experiences in parenteral manufacturing QMS / IPQA. Candidate worked in compliances / remediation / and having experiences of managing quality system document CCN / CAPA / investigation etc.
Assist in the development of regulatory strategies and implementation in an effort to manage complex issues that may have a significant impact on the Company’s internal and external product portfolio and product approval process.
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.